New Insights into the Modification of the Non-Core Metabolic Pathway of Steroids in Mycolicibacterium and the Application of Fermentation Biotechnology in C-19 Steroid Production
Open Access
- 9 March 2023
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (6) , 5236
Abstract
Androsta-4-ene-3,17-dione (AD), androsta-1,4-diene-3,17-dione (ADD), and 9α-hydroxy-4-androstene-3,17-dione (9-OHAD), which belong to C-19 steroids, are critical steroid-based drug intermediates. The biotransformation of phytosterols into C-19 steroids by Mycolicibacterium cell factories is the core step in the synthesis of steroid-based drugs. The production performance of engineered mycolicibacterial strains has been effectively enhanced by sterol core metabolic modification. In recent years, research on the non-core metabolic pathway of steroids (NCMS) in mycolicibacterial strains has made significant progress. This review discusses the molecular mechanisms and metabolic modifications of NCMS for accelerating sterol uptake, regulating coenzyme I balance, promoting propionyl-CoA metabolism, reducing reactive oxygen species, and regulating energy metabolism. In addition, the recent applications of biotechnology in steroid intermediate production are summarized and compared, and the future development trend of NCMS research is discussed. This review provides powerful theoretical support for metabolic regulation in the biotransformation of phytosterols.Keywords
Funding Information
- National Natural Science Foundation of China (32100065, ZR2018QC002, 318052041)
- Natural Science Foundation of Shandong Province of China (32100065, ZR2018QC002, 318052041)
- Doctoral Research Startup Foundation of Liaocheng University (32100065, ZR2018QC002, 318052041)
This publication has 120 references indexed in Scilit:
- A Novel Role of the PrpR as a Transcription Factor Involved in the Regulation of Methylcitrate Pathway in Mycobacterium tuberculosisPLOS ONE, 2012
- Antigen 85C Inhibition Restricts Mycobacterium tuberculosis Growth through Disruption of Cord Factor BiosynthesisAntimicrobial Agents and Chemotherapy, 2012
- SQ109 Targets MmpL3, a Membrane Transporter of Trehalose Monomycolate Involved in Mycolic Acid Donation to the Cell Wall Core of Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2012
- Cholesterol Catabolism by Mycobacterium tuberculosis Requires Transcriptional and Metabolic AdaptationsChemistry & Biology, 2012
- Cholesterol catabolism as a therapeutic target in Mycobacterium tuberculosisTrends in Microbiology, 2011
- Accumulation of Non-Superoxide Anion Reactive Oxygen Species Mediates Nitrogen-Limited Alcoholic Fermentation by Saccharomyces cerevisiaeApplied and Environmental Microbiology, 2010
- Cholesterol Metabolism Increases the Metabolic Pool of Propionate in Mycobacterium tuberculosisBiochemistry, 2009
- Mycobacterial persistence requires the utilization of host cholesterolProceedings of the National Academy of Sciences, 2008
- The mechanism of superoxide production by NADH:ubiquinone oxidoreductase (complex I) from bovine heart mitochondriaProceedings of the National Academy of Sciences, 2006
- Identification of Two prpDBC Gene Clusters in Corynebacterium glutamicum and Their Involvement in Propionate Degradation via the 2-Methylcitrate CycleJournal of Bacteriology, 2002